---
id: ash-vte-thrombophilia-2023
title: "American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing"
short_title: "ASH VTE Thrombophilia 2023"

organization: American Society of Hematology
collaborators: null
country: US
url: https://ashpublications.org/bloodadvances/article/7/22/7101/495845/American-Society-of-Hematology-2023-guidelines-for
doi: 10.1182/bloodadvances.2023010177
pmid: 37195076
open_access: true

specialty: hematology
guideline_type: clinical-practice
evidence_system: GRADE
conditions:
  - venous thromboembolism
  - thrombophilia
  - deep vein thrombosis
  - pulmonary embolism
tags:
  - factor V Leiden
  - prothrombin mutation
  - antiphospholipid syndrome
  - protein C
  - protein S
  - genetic testing

publication_date: 2023-05-17
previous_version_date: null
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-21
---

## Scope

Evidence-based guideline addressing when and how to test for hereditary and acquired thrombophilia in patients with venous thromboembolism, and how testing results should guide management decisions.

## Notes

Part of ASH's comprehensive VTE guideline series. Other ASH VTE guidelines cover: treatment of DVT/PE (2020), prevention in surgical patients (2019), and cancer-associated VTE (2021).
